Growing community of inventors

Richmond, CA, United States of America

Phillip Tam

Average Co-Inventor Count = 4.80

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 94

Phillip Tam ↔ David Paschon (6 patents)Phillip Tam ↔ Fyodor Urnov (5 patents)Phillip Tam ↔ Philip D Gregory (5 patents)Phillip Tam ↔ Russell DeKelver (4 patents)Phillip Tam ↔ Michael C Holmes (1 patent)Phillip Tam ↔ Dmitry Y Guschin (1 patent)Phillip Tam ↔ Dmitry M Guschin (1 patent)Phillip Tam ↔ Russell DeKeiver (1 patent)Phillip Tam ↔ Fyodor Urnov (1 patent)Phillip Tam ↔ Russell Dekelver (1 patent)Phillip Tam ↔ Russell Dekelver (0 patent)Phillip TamPhillip Tam (6 patents)David PaschonDavid Paschon (49 patents)Fyodor UrnovFyodor Urnov (80 patents)Philip D GregoryPhilip D Gregory (62 patents)Russell DeKelverRussell DeKelver (15 patents)Michael C HolmesMichael C Holmes (64 patents)Dmitry Y GuschinDmitry Y Guschin (8 patents)Dmitry M GuschinDmitry M Guschin (5 patents)Russell DeKeiverRussell DeKeiver (1 patent)Fyodor UrnovFyodor Urnov (38 patents)Russell DekelverRussell Dekelver (7 patents)Russell DekelverRussell Dekelver (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Sangamo Biosciences, Inc. (4 from 160 patents)

2. Sangamo Therapeutics, Inc. (2 from 145 patents)


6 patents:

1. 11649468 - Targeted integration into the PPP1R12C locus

2. 9914940 - Targeted integration into the PPP1R12C locus

3. 9267154 - Targeted integration into the PPP1R12C locus

4. 9161995 - Methods and compositions for alteration of a cystic fibrosis transmembrane conductance regulator (CFTR) gene

5. 8822221 - Targeted integration into the PPP1R12C locus

6. 8110379 - Targeted integration into the PPP1R12C locus

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/7/2025
Loading…